{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:00:56Z","timestamp":1787032856485,"version":"build-2736575974"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,6]]},"DOI":"10.7759\/cureus.63983","type":"journal-article","created":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T15:12:12Z","timestamp":1720278732000},"source":"Crossref","is-referenced-by-count":1,"title":["Transient Hyperglycemia in a Patient With Type 2 Diabetes After COVID-19 Messenger RNA Vaccination: A Case Report"],"prefix":"10.7759","author":[{"given":"Aniebietabasi","family":"Okon-Umoren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Yaphe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla D","family":"Passalacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Budzynska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2020.02012","article-title":"How new models of vaccine development for COVID-19 have helped address an epic public health crisis","volume":"40","author":"Bloom DE","year":"2021","unstructured":"Bloom DE, Cadarette D, Ferranna M, Hyer RN, Tortorice DL. How new models of vaccine development for COVID-19 have helped address an epic public health crisis. Health Aff (Millwood). 2021, 40:410-8. 10.1377\/hlthaff.2020.02012","journal-title":"Health Aff (Millwood)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00526-x","article-title":"COVID-19 vaccines: modes of immune activation and future challenges","volume":"21","author":"Teijaro JR","year":"2021","unstructured":"Teijaro JR, Farber DL. COVID-19 vaccines: modes of immune activation and future challenges. Nat Rev Immunol. 2021, 21:195-7. 10.1038\/s41577-021-00526-x","journal-title":"Nat Rev Immunol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.576818","article-title":"Impact of diabetes in patients diagnosed with COVID-19","volume":"11","author":"Abu-Farha M","year":"2020","unstructured":"Abu-Farha M, Al-Mulla F, Thanaraj TA, Kavalakatt S, Ali H, Abdul Ghani M, Abubaker J. Impact of diabetes in patients diagnosed with COVID-19. Front Immunol. 2020, 11:576818. 10.3389\/fimmu.2020.576818","journal-title":"Front Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00124.2020","article-title":"COVID-19 pandemic, coronaviruses, and diabetes mellitus","volume":"318","author":"Muniyappa R","year":"2020","unstructured":"Muniyappa R, Gubbi S. COVID-19 pandemic, coronaviruses, and diabetes mellitus. Am J Physiol Endocrinol Metab. 2020, 318:E736-41. 10.1152\/ajpendo.00124.2020","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou F","year":"2020","unstructured":"Zhou F, Yu T, Du R, et al.. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020, 395:1054-62. 10.1016\/S0140-6736(20)30566-3","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-2260","article-title":"COVID-19 severity is tripled in the diabetes community: a prospective analysis of the pandemic's impact in type 1 and type 2 diabetes","volume":"44","author":"Gregory JM","year":"2021","unstructured":"Gregory JM, Slaughter JC, Duffus SH, et al.. COVID-19 severity is tripled in the diabetes community: a prospective analysis of the pandemic's impact in type 1 and type 2 diabetes. Diabetes Care. 2021, 44:526-32. 10.2337\/dc20-2260","journal-title":"Diabetes Care"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.01.014","article-title":"Multiple early factors anticipate post-acute COVID-19 sequelae","volume":"185","author":"Su Y","year":"2022","unstructured":"Su Y, Yuan D, Chen DG, et al.. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022, 185:881-895.e20. 10.1016\/j.cell.2022.01.014","journal-title":"Cell"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.02.026","article-title":"COVID-19 vaccination in patients with diabetes mellitus: current concepts, uncertainties and challenges","volume":"15","author":"Pal R","year":"2021","unstructured":"Pal R, Bhadada SK, Misra A. COVID-19 vaccination in patients with diabetes mellitus: current concepts, uncertainties and challenges. Diabetes Metab Syndr. 2021, 15:505-8. 10.1016\/j.dsx.2021.02.026","journal-title":"Diabetes Metab Syndr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10030454","article-title":"COVID-19 vaccines and hyperglycemia-is there a need for postvaccination surveillance?","volume":"10","author":"Samuel SM","year":"2022","unstructured":"Samuel SM, Varghese E, Triggle CR, B\u00fcsselberg D. COVID-19 vaccines and hyperglycemia-is there a need for postvaccination surveillance?. Vaccines (Basel). 2022, 10:454. 10.3390\/vaccines10030454","journal-title":"Vaccines (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30068-2","article-title":"Glycaemic control is associated with SARS-CoV-2 breakthrough infections in vaccinated patients with type 2 diabetes","volume":"13","author":"Marfella R","year":"2022","unstructured":"Marfella R, Sardu C, D'Onofrio N, et al.. Glycaemic control is associated with SARS-CoV-2 breakthrough infections in vaccinated patients with type 2 diabetes. Nat Commun. 2022, 13:2318. 10.1038\/s41467-022-30068-2","journal-title":"Nat Commun"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvab141","article-title":"Hyperglycemic emergencies associated with COVID-19 vaccination: a case series and discussion","volume":"5","author":"Lee HJ","year":"2021","unstructured":"Lee HJ, Sajan A, Tomer Y. Hyperglycemic emergencies associated with COVID-19 vaccination: a case series and discussion. J Endocr Soc. 2021, 5:bvab141. 10.1210\/jendso\/bvab141","journal-title":"J Endocr Soc"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.05.024","article-title":"Exacerbation of hyperglycemia in patients with type 2 diabetes after vaccination for COVID19: report of three cases","volume":"15","author":"Mishra A","year":"2021","unstructured":"Mishra A, Ghosh A, Dutta K, Tyagi K, Misra A. Exacerbation of hyperglycemia in patients with type 2 diabetes after vaccination for COVID19: report of three cases. Diabetes Metab Syndr. 2021, 15:102151. 10.1016\/j.dsx.2021.05.024","journal-title":"Diabetes Metab Syndr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14631","article-title":"Acute hyperglycaemic crisis after vaccination against COVID-19: a case series","volume":"38","author":"Edwards AE","year":"2021","unstructured":"Edwards AE, Vathenen R, Henson SM, Finer S, Gunganah K. Acute hyperglycaemic crisis after vaccination against COVID-19: a case series. Diabet Med. 2021, 38:e14631. 10.1111\/dme.14631","journal-title":"Diabet Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14125","article-title":"COVID-19 vaccine and hyperosmolar hyperglycemic state","volume":"13","author":"Abu-Rumaileh MA","year":"2021","unstructured":"Abu-Rumaileh MA, Gharaibeh AM, Gharaibeh NE. COVID-19 vaccine and hyperosmolar hyperglycemic state. Cureus. 2021, 13:e14125. 10.7759\/cureus.14125","journal-title":"Cureus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13781","article-title":"Type 1 diabetes mellitus following COVID-19 RNA-based vaccine","volume":"13","author":"Sakurai K","year":"2022","unstructured":"Sakurai K, Narita D, Saito N, et al.. Type 1 diabetes mellitus following COVID-19 RNA-based vaccine. J Diabetes Investig. 2022, 13:1290-2. 10.1111\/jdi.13781","journal-title":"J Diabetes Investig"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2020.11.006","article-title":"SARS-CoV-2 cell entry factors ACE2 and TMPRSS2 are expressed in the microvasculature and ducts of human pancreas but are not enriched in \u03b2 cells","volume":"32","author":"Coate KC","year":"2020","unstructured":"Coate KC, Cha J, Shrestha S, et al.. SARS-CoV-2 cell entry factors ACE2 and TMPRSS2 are expressed in the microvasculature and ducts of human pancreas but are not enriched in \u03b2 cells. Cell Metab. 2020, 32:1028-40.e4. 10.1016\/j.cmet.2020.11.006","journal-title":"Cell Metab"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/266427-transient-hyperglycemia-in-a-patient-with-type-2-diabetes-after-covid-19-messenger-rna-vaccination-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T15:12:14Z","timestamp":1720278734000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/266427-transient-hyperglycemia-in-a-patient-with-type-2-diabetes-after-covid-19-messenger-rna-vaccination-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,6]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.63983","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,6]]}}}